Luippold G, Mark M, Klein T, Amann KU, Daniel C (2018)
Publication Type: Journal article
Publication year: 2018
Book Volume: 143
Pages Range: 199-203
DOI: 10.1016/j.diabres.2018.07.009
The two dipeptidyl peptidase (DPP)-4 inhibitors, linagliptin and sitagliptin, were shown to exert different binding kinetics in vitro. Twenty-four hours after oral dosing particularly in vivo inhibition of renal-specific DPP-4 activity was more sustained in Sprague Dawley rats after exposure to linagliptin than it was after sitagliptin.
APA:
Luippold, G., Mark, M., Klein, T., Amann, K.U., & Daniel, C. (2018). Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin. Diabetes Research and Clinical Practice, 143, 199-203. https://doi.org/10.1016/j.diabres.2018.07.009
MLA:
Luippold, Gerd, et al. "Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin." Diabetes Research and Clinical Practice 143 (2018): 199-203.
BibTeX: Download